Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02075892 · ClinicalTrials.gov registry record · NA

Mushroom Blend on Oxygen Kinetics

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT02075892: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT02075892 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02075892, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

Purpose: To determine the acute effects of a mushroom blend vs. placebo on oxygen kinetics, aerobic power and time to fatigue in healthy adults.

Primary Outcome

oxygen uptake and utilization using indirect calorimetry during a 6 min steady-state exercise bout

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Mushroom Blend

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-08
Est. Completion 2014-12
Phase NA

What the finished NCT02075892 record still lists

NCT02075892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02075892 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02075892 about?

NCT02075892 is a clinical study titled "Mushroom Blend on Oxygen Kinetics". Purpose: To determine the acute effects of a mushroom blend vs. placebo on oxygen kinetics, aerobic power and time to fatigue in healthy adults.

What is the current status of trial NCT02075892?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-08. Estimated completion is 2014-12.

What interventions are being tested in trial NCT02075892?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Mushroom Blend (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02075892?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02075892's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02075892, the US trial registry maintained by the National Library of Medicine. NCT02075892 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.